Guidance and educational insights about peptide therapy protocols are also shared through Dr
Heres a list of important things to consider when deciding whether or not to stop a seizure medication: Duration of seizure freedom (longer seizure-free period, often 25 years, lowers recurrence risk) Type of epilepsy syndrome or seizure classification Age at seizure onset (childhood-onset epilepsies often have better remission rates) Presence of structural brain disease (tumor, stroke, traumatic brain injury, cortical malformation) Number of antiseizure medications required for seizure control (monotherapy vs polytherapy) Seizure frequency prior to achieving control Duration of epilepsy before remission occurred Patient safety considerations if a seizure were to recur (driving, occupational risks, injury risk) Adverse effects or medication burden (cognitive effects, drug interactions, bone health concerns, teratogenic risk) I also wanted to discuss individual agents when considering whether or not to taper seizure medications and how that is typically done
Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
If patients revert to poor habits, weight regain is possible
Physical Therapy and Manual Therapies Physical therapy, massage therapy, and other manual therapies can help to manage pain and support mobility
